The latest EJPRD newsletter is now online.

2 – 31 December 2020

Please, read it online clicking on the link we provide.

The European Joint Programme on Rare Diseases (EJP RD) brings over 130 institutions (including all 24 ERNs)  from 35 countries:

  • 26 EU Member States (Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Croatia, Ireland, Italy, Netherlands, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Spain, Sweden, Slovakia, Slovenia)
  • 7 associated (Armenia, Georgia, Israel, Norway, Serbia, Switzerland, Turkey)
  • Uk & Canada

to create a comprehensive, sustainable ecosystem allowing a virtuous circle between research, care and medical innovation.

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern